Anne-Kathrin Stoller to Become New CEO at Bachem
Bubendorf, Switzerland--(Newsfile Corp. - October 31, 2025) - Ad hoc announcement pursuant to Art. 53 LR Anne-Kathrin Stoller to become new CEO at Bachem Bachem (SIX: BANB) announced today that its Board of Directors has appointed Anne-Kathrin Stoller, currently Head of Bachem Americas and previously the company's long-standing Chief Marketing Officer (CMO), as its new CEO, effective January 1, 2026. She succeeds Thomas Meier, who, after more than thirty years at Bachem and nearly six years...
2025-10-31 2:23 AM EDT
Bachem Announces Progress in Building K Start-Up and Expansion of Its Site in Vista, CA
Bubendorf, Switzerland--(Newsfile Corp. - October 23, 2025) - Bachem, a leading partner in peptide and oligonucleotide manufacturing, today announced progress in its plans to expand capacity. In Bubendorf, Building K was inspected by the local regulatory authorities (RHI). Based on feedback from the authorities, no delay is expected with r
2025-10-23 1:01 AM EDT
Bachem Expands Corporate Executive Committee to Include Chief Operations Officer Role
Bubendorf, Switzerland--(Newsfile Corp. - August 20, 2025) - The Bachem Group (SIX: BANB) announced today that Hans Van Hees, currently Chief Operations Officer Europe, will take on the role of Chief Operations Officer (COO) and join the Corporate Executive Committee (CEC) as of September 1, 2025. In this role, he will report to the CEO of Bachem, Thomas Meier, and will lead Bachem’s worldwide manufacturing network. Thomas Meier, who, in addition to his role as CEO, had also taken on the...
2025-08-20 1:08 AM EDT
Bachem Shows Strong Growth in the First Half of 2025
Bubendorf, Switzerland--(Newsfile Corp. - July 24, 2025) - Ad hoc announcement pursuant to Art. 53 LR Media Release Bachem shows strong growth in the first half of 2025 Group sales showed strong growth reaching CHF 313.0 million (+30.2% compared to the prior-year period, +34.1% in local currencies). EBITDA grew to CHF 91.0 million (+64.0% compared to the prior-year period, +76.
2025-07-24 1:14 AM EDT
Bachem Mourns the Loss of Company Founder Dr. H.C. Peter Grogg
Bubendorf, Switzerland--(Newsfile Corp. - June 3, 2025) - The founder and honorary chairman of Bachem (SIX: BANB) Peter Grogg, passed away on Monday, June 2, 2025, at the age of 83. Peter Grogg founded Bachem in 1971 and built the company from a two-person operation into the global market leader for the chemical synthesis of peptides. Peter Grogg was CEO of the company for over 30 years until 2002 and Chairman of the Board of Directors of Bachem Holding AG until 2012. His daughter Nicole...
2025-06-03 12:49 PM EDT
Bachem Annual General Meeting 2025
Bubendorf, Switzerland--(Newsfile Corp. - April 30, 2025) - Bachem Holding AG (SIX: BANB) (“Bachem”) announced today that its Annual General Meeting 2025 has approved all proposals of the Board of Directors. A total of 79.7% of the 74‘977‘940 eligible shares were present. The Annual General Meeting approved a dividend of CHF 0.85 per share. The dividend will be paid on May 7, 2025. The last trading day entitling to receive the dividend is May 2, 2025. As of May 5, 2025, the shares will be...
2025-04-30 11:55 AM EDT
Additional Member for the Board of Directors of Bachem Holding AG
Bubendorf, Switzerland--(Newsfile Corp. - April 3, 2025) - Bachem (SIX: BANB) announced today that the Board of Directors will recommend the election of Dr. Simone Wyss Fedele, CEO of Switzerland Global Enterprise, to the Annual General Meeting on April 30, 2025. All current members of the Board of Directors will stand for re-election. Dr. Kuno Sommer, Chairman of the Board of Directors, remarked: “I am very pleased that we can propose a leader like Simone Wyss Fedele for election as a new...
2025-04-03 9:27 AM EDT
Bachem Increases Sales and Profitability
Ad hoc announcement pursuant to Art. 53 LR Media Release Bachem increases sales and profitability Group sales rise to CHF 605.3 million (+4.8%) in 2024. EBITDA increases to CHF 176.3 million (+5.7%). EBITDA margin lies at 29.1%. In local currencies sales rise by 5.6% and EBITDA increases by 7.7% to a margin of 29.4%. Board of Directors proposes an
2025-02-27 1:42 AM EST
Bachem with Slight Sales Growth in the First Half of 2024. Outlook Confirmed for Full Year
Ad hoc announcement pursuant to Art. 53 LR Media Release Dear Sir or Madam Due to server overload our website is currently unavailable, including half year documents. We are therefore providing you with a separate link for half year information to ensure you have access to all documentation. Please accept our sincerest apologies for this inconvenience. Kind Regards Bachem Group Communic
2024-07-25 1:08 AM EDT